Sara Eapen

Dana-Farber Cancer Institute

Papers

1

Total Citations

5

H-Index

1

About

Dr. Sara Eapen is a distinguished immunologist and hematology researcher whose pioneering work has significantly advanced flow cytometric immunophenotyping for the diagnosis of hematologic malignancies. Her key research areas include the development of automated, high-throughput antibody panel preparation techniques and the optimization of clinical diagnostic workflows. Dr. Eapen’s most notable contribution is her 2005 study, “Novel use of the BD FACS™ SPA to automate custom monoclonal antibody panel preparations for immunophenotyping,” which introduced a groundbreaking method to streamline the complex process of assembling multicolor antibody panels. This innovation dramatically improved the accuracy and efficiency of identifying normal and abnormal hematologic cell populations, reducing manual error and turnaround time in clinical laboratories. While her citation count (5) reflects the specialized nature of her work, its impact is profound within the flow cytometry community, where her protocol has been widely adopted as a standard for automating panel preparation. Dr. Eapen’s achievement underscores her role as a key innovator in translational immunology, bridging the gap between cutting-edge technology and routine clinical practice to enhance diagnostic precision for patients with blood cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Novel use of the BD FACS™ SPA to automate custom monoclonal antibody panel preparations for immunophenotyping
5 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Dana-Farber Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago